$YSG

Yatsen Announces Second Quarter 2026 Financial Results

Yatsen (YSG) reported Q2 2026 revenue growth of 5.1% to $168.3M, driven by a 40.4% increase in skincare sales. Gross margin fell to 73.9% from 78.3% due to higher inventory provisions. Net loss widened to $13.4M from $1.9M. The company is refocusing on high-growth skincare brands.

Original reporting
Published Sep 2, 2026, 9:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 10:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Yatsen Announces Second Quarter 2026 Financial Results — source image
Decision brief

The 30-second read

$YSGBearishHigh
01

Why it matters

The earnings miss and expanding loss suggest near‑term downside risk, but the strong skincare growth and solid cash balance could support a longer‑term upside if the company successfully pivots away from low‑margin color cosmetics.

02

Market read

YSG's earnings release is a primary corporate event that can move the stock in pre‑market trading and may influence peer valuations in the Chinese beauty sector.

03

What to watch

Cash position remains strong at RMB1.06B, providing runway for strategic investments and potential cost‑cutting initiatives.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Yatsen is a China‑based beauty group listed on NYSE (YSG) that focuses on skincare and color cosmetics. The Q2 2026 release provides the first public disclosure of its latest financial performance.

Company-level read

Ticker impact

$YSGBearishHigh confidence
Context

Yatsen Holding Limited released its Q2 2026 unaudited results, showing a net loss of RMB90.8M and a 5.1% revenue increase, with skincare driving growth but margins compressing.

Expected impact

Downward pressure likely in pre‑market trading, with potential for further decline if guidance remains weak.

Evidence & confidence

The company posted a larger loss versus the prior year and a margin decline, while revenue growth was modest. Investors typically react negatively to widening losses, especially for a company with a high expense base.

Market effects

Highlights continued shift toward high‑margin skincare within the Chinese beauty sector, pressuring color‑cosmetics peers.

May weigh on other China‑listed beauty stocks as investors reassess profitability amid rising marketing costs.

Limited; primarily affects investors with exposure to Chinese consumer discretionary equities.

Counterpoint

If skincare momentum accelerates faster than anticipated, the loss could be a short‑term blip and the stock may rebound on margin improvement.

Key entities

  • Jinfeng Huang

    Founder, Chairman and CEO of Yatsen, provided commentary on strategic focus.

  • Donghao Yang

    CFO of Yatsen, discussed financial results and expense trends.

Related articles

$YSGMed

Yatsen Holding Q2 Loss Widens, Shares Down

Yatsen Holding Ltd. (YSG) reported a wider Q2 2026 loss, with net loss increasing to $13.39M from $17.67M YoY, due to higher expenses. Revenue rose to $168.34M from $108.6M. Shares fell 4.51% premarket. The company forecasts Q3 revenue between $898.6M and $998.4M, a potential YoY decrease of 0% to 10%.

$YSGMed

Yatsen Holding Ltd (YSG): Financial results for Q2 2026

Yatsen Holding Ltd (YSG) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Yatsen Announces Second Quarter 2026 Financial Results Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on September 2, 2026 GUANGZHOU, China, September 2, 2026 – Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty gr

$YSGHighAI 9/10

Transcript: Yatsen Holding Q1 2026 Earnings Conference Call - Yatsen Holding (NYSE:YSG)

Yatsen Holding reported Q1 2026 results on a conference call. The company said total net revenues rose 22.5% year over year to $1.02 billion, driven by a 58.5% increase from skincare brands, partially offset by a 5% decline in COVID cosmetics. Gross profit rose 24.3% to $819.2 million; gross margin increased to 80.2%. Operating expenses rose 32.5% to $918.1 million, with selling and marketing up to $737.2 million. The company also said it completed a May 21, 2026 closing of a convertible notes/w

$REXMed

REX AMERICAN RESOURCES Corp (REX): Results of Operations and Financial Condition

REX AMERICAN RESOURCES Corp (REX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99 REX American Resources Reports Record Fiscal Second Quarter 2026 Net Income Per Share Attributable to REX Common Shareholders of $1.06 vs. $0.22 in Fiscal Second Quarter 2025 Company receives Class VI injection well draft permit from U.S. EPA ▪ Generated $1.06 of net i

$GIIIMedAI 8/10

Why is G-III Apparel stock sliding today?

G-III Apparel (GIII) shares fell 9.9% to $29.00 after reporting Q2 2027 results. Revenue declined 9.6% YoY to $554.1M, missing estimates, while Q3 guidance of $870M was 3.2% below consensus. Adjusted EBITDA missed by 12.4%. The company faces a $470M revenue loss from expiring Calvin Klein and Tommy Hilfiger licenses. CEO Morris Goldfarb cited strong execution and optimism around the Marc Jacobs acquisition.